IS8222A - Vefjaverndandi frumuboðar til þess að vernda, endurheimta og bæta svarbúnar frumur, vefi og líffæri, og hafa lengda meðferðargetu - Google Patents

Vefjaverndandi frumuboðar til þess að vernda, endurheimta og bæta svarbúnar frumur, vefi og líffæri, og hafa lengda meðferðargetu

Info

Publication number
IS8222A
IS8222A IS8222A IS8222A IS8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A
Authority
IS
Iceland
Prior art keywords
restore
organs
tissues
tissue
protect
Prior art date
Application number
IS8222A
Other languages
English (en)
Icelandic (is)
Inventor
Cerami Anthony
Brines Michael
Coleman Thomas
Original Assignee
The Kenneth S. Warren Institute, Inc.
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Kenneth S. Warren Institute, Inc., H. Lundbeck A/S filed Critical The Kenneth S. Warren Institute, Inc.
Publication of IS8222A publication Critical patent/IS8222A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS8222A 2004-05-20 2006-01-10 Vefjaverndandi frumuboðar til þess að vernda, endurheimta og bæta svarbúnar frumur, vefi og líffæri, og hafa lengda meðferðargetu IS8222A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Publications (1)

Publication Number Publication Date
IS8222A true IS8222A (is) 2006-01-10

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8222A IS8222A (is) 2004-05-20 2006-01-10 Vefjaverndandi frumuboðar til þess að vernda, endurheimta og bæta svarbúnar frumur, vefi og líffæri, og hafa lengda meðferðargetu

Country Status (7)

Country Link
CN (1) CN1897960A (pt)
AU (1) AU2004319797A1 (pt)
BR (1) BRPI0412869A (pt)
IL (1) IL172036A0 (pt)
IS (1) IS8222A (pt)
NO (1) NO20062506L (pt)
WO (1) WO2005117927A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (en) * 2017-10-10 2019-04-18 Augustinus Bader APPLICATION OF ERYTHROPOIETIN (EPO) IN SPINAL CORD LESION (LME) THERAPY THERAPY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
NZ542092A (en) * 2003-03-27 2008-04-30 Janssen Pharmaceutica Nv Use of erythropoietin (EPO) in stroke recovery wherein the EPO is formulated for administration for a particular dosage regime

Also Published As

Publication number Publication date
WO2005117927A2 (en) 2005-12-15
AU2004319797A8 (en) 2008-12-11
NO20062506L (no) 2006-05-31
AU2004319797A1 (en) 2006-01-12
CN1897960A (zh) 2007-01-17
IL172036A0 (en) 2009-02-11
WO2005117927A3 (en) 2006-05-11
BRPI0412869A (pt) 2006-10-03

Similar Documents

Publication Publication Date Title
IS7604A (is) Raðbreyttir vefjaverndandi frumuboðar og kjarnsýrur sem tákna þá, gerðir til þess að vernda, lagfæra og bæta svarbúnar frumur, vefi og líffæri
DK2921500T5 (da) Genetisk modificerede, humane, naturlige dræbercellelinjer
IS7619A (is) Vefjaverndandi frumuboðar til þess að vernda, endurheimta og bæta svarbúnar frumur, vefi og líffæri
IL272587B (en) Adherent cells from placental tissue and their use in healing
IS8075A (is) Viðtakaflóki vefjaverndandi frumuboða, mælingar til þess að bera kennsl á vefjaverndandi efnasambönd og notkun þeirra
IL164079A0 (en) Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
DK1905117T3 (da) Forbedrede perfluorerede membraner og forbedrede elektrolytter til redoxceller og batterier
DE112004002289D2 (de) Elektrochemische Batteriezelle
IS8156A (is) Vefjaverndandi frumuboðar til þess að vernda, endurheimta og bæta svarbúnar frumur, vefi og líffæri, og hafa lengda meðferðargetu
EP2210622A4 (en) THERAPEUTIC AGENT AGAINST DISEASE FOR CELL TRANSPLANT THERAPY USE
IL187491A0 (en) Controlled electroporation and mass treansfer across cell membranes in tissue
EP1851814A4 (en) SECONDARY BATTERY WITH IMPROVED LITHIUM MOBILITY AND CELL CAPACITY
EP1809740A4 (en) HEART STEM CELLS
IL181887A0 (en) Fetal skin cell protein compositions
SI1926813T2 (sl) Celična populacija z imunoregulatorno aktivnostjo, postopek za izolacijo in uporabe
DK2730277T3 (da) Lægemiddelbærer og lægemiddelbærerkit til at inhibere fibrose
IL242645B (en) Angiogenic cells from human placental perfusate
EP2214426A4 (en) CELL SELECTION SYSTEM, CELL SELECTION METHOD, AND PORTABLE TERMINAL
PL2203176T3 (pl) Hamowanie nowotworu za pomocą perfuzatu łożyska ludzkiego i ludzkich łożyskowych pośrednich komórek NK
EP1649021A4 (en) VEGETABLE CELL CYCLUSGEN AND USE METHOD
CY1111769T1 (el) Παρασκευη κυτταρων
PL1863905T3 (pl) Sposób aktywacji naturalnych komórek zabójców preparatami komórek guza in vitro
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
ZA200703293B (en) Cell bandage
IS8090A (is) Samsetning til að bæta vitsmuni og minni